S. Korea Pharma Group’s President Under Fire For Kickbacks
This article was originally published in PharmAsia News
Executive Summary
The head of South Korea's pharmaceutical association and his company face questions by the group's fair trade committee over kickback allegations. Auh June-sun is president of the Korea Pharmaceutical Manufacturers Association and chairman of Ahngook Pharm. The company was reported to have paid kickbacks to physicians for prescribing the firm's products. The company is expected to be punished by the association and the administration while the National Assembly ponders legislation to punish recipients of such kickbacks. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.